FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003.

First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...

The AstraZeneca vaccine FluMist, which is administered in nasal spray form, was first approved by the FDA in 2003 for people ...

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...

No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was ...

Dr. Curiel says vaccines in nasal form target the airway, where a respiratory virus enters the body. “A systemic injection, like MRNA, will augment antibodies in the blood, not so much in the lung.

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...

FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...

The U.S. Food and Drug Administration on Friday approved the first flu vaccine that comes in the form of a nasal spray and ...

The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.